Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 29, 2024Metabolism and Target Organ DamageOpen Access

Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease

View Full Paper
Ask AI
Bookmark
Share

Authors

HDHailemichael DesalegnRFR.H.A. FariasDHD.G. Hudson

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Desalegn et al. (2024) studied this question.

synapsesocial.com/papers/68e5ea38b6db64358757efd6https://doi.org/10.20517/mtod.2024.30
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups2024 · 3 citations
  2. 2Global burden of liver disease: 2023 update2023 · 2,166 citations
  3. 3Genetic and Epigenetic Modifiers of Alcoholic Liver Disease2018 · 105 citations
  4. 4Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis2018 · 158 citations
  5. 5Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study2023 · 145 citations